You searched for "cosmeceuticals"

78 results found

ACE 2024

ACE, the leading aesthetics conference and exhibition, returns for 2024 with two unmissable days of networking and educational content. Taking place on 15–16 March at the Business Design Centre in London, ACE 2024 is the must-attend event for all medical...

Bruxism: a practical guide to treatment with botulinum toxin type A

The aetiology of bruxism is outlined and referenced, giving a clear context to the reader. Recommended treatment options are listed, with a brief summary of the evidence concerning pharmaceutical options, oral appliances, splints, psychology and physiotherapy. The author discusses a...

Treatment of facial subcutaneous fibrosis with hyaluronic acid

This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. Systemic sclerosis (SSc) is a rare and chronic connective tissue disease (CTD)...

Hello and goodbye: changes to The PMFA Journal Editorial Board

The PMFA Journal team are delighted to welcome three new Specialist Advisors to our Editorial Board, each of whom will broaden our expertise and offer new perspectives to the Journal.

How I Do It - Contouring the lower jaw (surgical)

It is essential to clearly understand the patient’s needs so I usually see patients three to four times prior to operating if major changes to appearance are planned. You must also be able to manage expectations and postoperative outcomes; for...

A short overview of the evolution of botulinum toxin type A formulations

Botulinum toxin type A (BoNT-A) is a potent neurotoxin produced by the bacterium Clostridium botulinum [1]. BoNT-A has been used for various therapeutic and aesthetic purposes, including the treatment of muscle disorders, chronic pain and facial wrinkles [2-4]. Over the...

IMCAS 2023

Ethics in Aesthetic Medicine: presented the Consensus Paper of the major international experts

What’s new in treating hypertrophic scars and keloids?

World renowned dermatologist, Michael H Gold, explains new treatments available in the challenging field of hypertrophic scar and keloid management. The treatment of hypertrophic scars and keloids remains one of the most challenging conditions that dermatologists face on a regular...

FACE 2015

This was undoubtedly the biggest and most prestigious UK conference of the year. The international mix of both delegates and presenters brought together knowledge, skill and allowed us to experience a jam-packed agenda covering all aspects of aesthetic medicine. The...

Gross Negligence Manslaughter in Healthcare: The medico-legal dilemma (part 16) – Aggravating factors

The Judge just cannot say, “Lee’s airway and oxygenation were not established or maintained”. This is nonsensical from the perspective of a person trained in medicine. Even more senseless from a person who is not. If Lee’s airway was not established and maintained, how did Lee survive a three-hour operation, albeit in the prone position and without developing any signs of cyanosis?

The 5 Rs of the renaissance. The new paradigm in aesthetic medicine

The Renaissance was a period of great importance in human history where art and science came together to define ideal beauty. This same search for harmony is reflected in current aesthetic medicine, where proportion and symmetry are considered fundamental. For...

Xanthelasma

Although the lesion known as Xanthelasma was first described by Addison and Gall in 1851 [1] it was recorded some 300 years previously in the famous painting of the Mona Lisa by Leonardo da Vinci. In this painting, Leonardo da...